IRIS
AZZONI, Cinzia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.113
AS - Asia 2.734
EU - Europa 1.839
SA - Sud America 370
AF - Africa 169
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.232
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.019
SG - Singapore 938
CN - Cina 812
VN - Vietnam 469
IE - Irlanda 319
IT - Italia 309
BR - Brasile 274
SE - Svezia 265
FI - Finlandia 243
HK - Hong Kong 200
DE - Germania 154
ZA - Sudafrica 115
UA - Ucraina 109
FR - Francia 96
GB - Regno Unito 73
NL - Olanda 71
TR - Turchia 68
CA - Canada 59
AT - Austria 50
IN - India 49
RU - Federazione Russa 47
AR - Argentina 41
BD - Bangladesh 30
BE - Belgio 25
IQ - Iraq 23
PL - Polonia 20
MX - Messico 18
JP - Giappone 17
PH - Filippine 17
EC - Ecuador 16
PK - Pakistan 16
MA - Marocco 15
ES - Italia 14
ID - Indonesia 12
UZ - Uzbekistan 11
CI - Costa d'Avorio 10
GR - Grecia 10
CO - Colombia 9
CZ - Repubblica Ceca 9
KR - Corea 8
LT - Lituania 8
CL - Cile 7
PE - Perù 7
VE - Venezuela 7
IR - Iran 6
KE - Kenya 6
AU - Australia 5
DZ - Algeria 5
ET - Etiopia 5
JO - Giordania 5
OM - Oman 5
TH - Thailandia 5
TW - Taiwan 5
BO - Bolivia 4
CY - Cipro 4
DO - Repubblica Dominicana 4
IL - Israele 4
MY - Malesia 4
PA - Panama 4
BH - Bahrain 3
DK - Danimarca 3
EG - Egitto 3
GE - Georgia 3
JM - Giamaica 3
KZ - Kazakistan 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CG - Congo 2
CR - Costa Rica 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
PT - Portogallo 2
AM - Armenia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.232
Salva come PNG Salva come JPEG
Città #
Singapore 550
Ashburn 466
Chandler 357
Dublin 319
San Jose 245
Santa Clara 201
Hong Kong 189
Beijing 157
Dallas 155
Ho Chi Minh City 148
Hanoi 112
Jacksonville 110
Johannesburg 106
Dearborn 105
Parma 100
Los Angeles 99
Boardman 95
Ann Arbor 92
New York 87
Shanghai 81
Nanjing 73
Lauterbourg 55
Princeton 48
Vienna 47
Izmir 44
Munich 40
Hefei 38
Jinan 37
Helsinki 34
São Paulo 32
Turku 30
Wilmington 30
Shenyang 28
San Mateo 27
Tianjin 25
Toronto 24
Da Nang 23
Chicago 22
Moscow 21
Seattle 21
Bologna 19
Columbus 19
Nanchang 19
Bremen 18
Brussels 18
Buffalo 17
Changsha 17
Hebei 17
Marseille 16
Tokyo 16
Warsaw 16
Woodbridge 16
London 15
Guangzhou 14
Kunming 14
Montreal 14
Pune 14
Atlanta 13
Frankfurt am Main 13
Haiphong 13
Ankara 12
Baghdad 12
Council Bluffs 12
Denver 12
Des Moines 12
Nuremberg 12
Rio de Janeiro 12
Hangzhou 11
Abidjan 10
The Dalles 10
Athens 9
Biên Hòa 9
Brooklyn 9
Manchester 9
Poplar 9
Redondo Beach 9
Stockholm 9
Tashkent 9
Haikou 8
Phoenix 8
Rio Saliceto 8
San Francisco 8
Taiyuan 8
Zhengzhou 8
Amsterdam 7
Chennai 7
Hải Dương 7
Jakarta 7
Ningbo 7
Orem 7
Ottawa 7
Paris 7
Castrezzato 6
City of London 6
Jiaxing 6
Louvain-la-Neuve 6
Modena 6
Nairobi 6
Norwalk 6
Quảng Ngãi 6
Totale 5.130
Salva come PNG Salva come JPEG
Nome #
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 202
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 192
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 185
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 184
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 178
Human Papilloma Virus (HPV) status, P16INK4a and p53 overexpression in epithelial malignant and borderline ovarian neoplasms 171
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 169
Histological subtype analysis of colon cancer: a population-based study. Different sides and different diseases. 168
ANASTOMOTIC RECURRENCE OF COLON CANCER: GENETIC ANALYSIS CHALLANGES THE WIDELY HELD THEORIES OF CANCEROUS CELLS’ INTRALUMINAL IMPLANTATION AND METACHRONOUS CARCINOGENESIS 167
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 165
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 161
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 161
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 160
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 160
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 159
Classification of gastric endocrine cells at the light and electron microscopical levels 158
Notch expression and bevacizumab efficacy in colorectal cancer patients 157
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 155
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 155
Different patterns of 11q allelic losses in digestive endocrine tumors 152
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 152
Atrophic body gastriris patients with enterochromaffin-like cell dysplasia are at increased risk for development of type I gastric carcinoid 149
Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1. 148
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 147
Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms. 147
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 146
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 145
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 144
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 144
Pancreatic Polypeptide-related tumors 143
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 143
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 141
Pleomorph poorly differentiated endocrine carcinoma of the rectum 141
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer 141
Primary Squamous Cell Carcinoma of the Endometrium Unrelated to Human Papilloma Virus: A Molecular Study 138
Microsatellite instability in colorectal cancer 138
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 138
Metaplastic papillary tumour of the salpinx: report of a case with microsatellite analysis 137
Monitoring cfDNA in plasma and in other liquid biopsies of advanced EGFR mutated NSCLC patients: A pilot study and a review of the literature 135
Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy 131
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 130
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 129
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 126
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 123
Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features 122
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 119
P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas 113
Surgical treatment of multiple sporadic colorectal carcinoma 109
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. 102
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 101
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 99
Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients 99
Prognostic immunoinflammatory and transcriptomic profiles in patients with pleural mesothelioma undergoing immunotherapy 96
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 93
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 92
BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature 88
MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patient 87
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study 85
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 80
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups 59
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making 52
Totale 8.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.203
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 7 32 4
2021/2022279 6 1 4 18 13 8 42 24 16 17 34 96
2022/20231.232 106 155 66 96 101 146 12 85 393 14 43 15
2023/2024435 27 29 9 7 30 121 42 41 17 24 25 63
2024/20251.433 36 65 97 104 175 182 74 50 162 108 119 261
2025/20263.523 335 248 414 460 565 246 348 140 533 234 0 0
Totale 8.311